| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | EVP, CFO &Treasurer
2 companies
Renz Justin A is a Chief Financial Officer at ARDELYX, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 4 sells.
Estimated insider holdings value: $2.6M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2021 | ARDX Ardelyx, Inc. | Chief Financial Officer | Sell | 612 | $7.09 | $4,337.73 | -1.5% | -79.9% | -90.4% | |
| Feb 22, 2021 | ARDX Ardelyx, Inc. | Chief Financial Officer | Sell | 608 | $6.88 | $4,184.56 | -1.5% | +0.4% | -90.1% | |
| Sep 15, 2020 | ARDX Ardelyx, Inc. | Chief Financial Officer | Sell | 3,714 | $5.49 | $20,372.78 | -28.6% | - | - | |
| Nov 9, 2016 | KPTI Karyopharm Therapeutics Inc. | EVP, CFO &Treasurer | Sell | 4,342 | $8.19 | $35,544.48 | -18.5% | - | - | |
| Apr 2, 2015 | KPTI Karyopharm Therapeutics Inc. | EVP, CFO &Treasurer | Buy | 5,000 | $29.71 | $148,557.00 | New | - | - |